| Category: | Medical & Pharma, Pharmaceuticals |
|---|---|
| Organizer: | KYUNGYON EXHIBITION CORP. |
| Exhibition center: | Korea International Exhibition Center (KINTEX) |
Hotels search near to Korea International Exhibition Center (KINTEX)
Overview interest facts - Korea Pharm & Bio 2024
Korea Pharm & Bio is the leading pharmaceutical and biopharma exhibition. Korea Pharm & Bio 2022 is an ideal opportunity for announcing the latest materials and technologies to Korea's pharmaceutical & bio-pharma industries as well as the Asia Pacific Region.
Overview of exhibitors / visitors - Korea Pharm & Bio 2024
Korea Pharm & Bio is a major expo for the pharmaceutical industry which was earlier participated by more than 500 companies, among which more than 400 were domestic and more than 160 were overseas participants. Aemtech Co. Ltd, EST and Humantech are some of exhibitors from previous edition. Active Pharma Ingredients/ APIs, Intermediates, Additives, Functional Ingredients, Natural Extracts, Fine Chemicals, OEM, Analytical Services & Equipment, Consulting and IT Services are some of the sectors of pharmaceuticals that are going to participate in the expo. Around 800 companies are going to participate in the expo from 25 countries with products belonging to those categories. The event will help in networking and improving brand image by displaying products to a huge customer base.
Recommended events
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023